Concepedia

J. Bichler

JB

15

Publications

448

Citations

13

H-Index

1988

Active since

Affiliations

Octapharma (Switzerland)(Current)

Ludwig-Maximilians-Universität München

Klinikum im Friedrichshain

University Specialized Hospital for Active Treatment of Endocrinology

München Klinik

J. Bichler is an author at Octapharma (Switzerland) specializing in hematology, thrombosis, and medicine.

Top concepts

Publications per year

1988–2018

15

Publications

15

Persistent thrombin generation in humans during specific thrombin inhibition with hirudin.

Pierre Zoldhelyi, J. Bichler, Whyte G. Owen et al. · Circulation · 1994 · 57 citations · Full text

<scp>PK</scp>‐guided personalized prophylaxis with Nuwiq<sup>®</sup> (human‐cl rh<scp>FVIII</scp>) in adults with severe haemophilia A

Toshko Lissitchkov, L. Rusen, Pencho Georgiev et al. · Haemophilia · 2017 · 51 citations · Full text

Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration.

J. Bichler, Burkhard Fichtl, Matthias Siebeck et al. · PubMed · 1988 · 47 citations

, , +13

Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).

Philippe Close, J. Bichler, Roger Kerry et al. · PubMed · 1994 · 39 citations

Novel, human cell line‐derived recombinant factor VIII (human‐cl rhFVIII; Nuwiq<sup>®</sup>) in adults with severe haemophilia A: efficacy and safety

Toshko Lissitchkov, K. K. Hampton, Mario von Depka et al. · Haemophilia · 2015 · 36 citations · Full text

Rows per page

1–5 of 15